Difference between revisions of "How I Treat"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
Line 106: Line 106:
 
*'''2023:''' Doreille et al. [https://doi.org/10.1182/blood.2022015583 How I treat thrombotic microangiopathy in the era of rapid genomics]
 
*'''2023:''' Doreille et al. [https://doi.org/10.1182/blood.2022015583 How I treat thrombotic microangiopathy in the era of rapid genomics]
 
*'''2021:''' Thomas & Scully. [http://www.ncbi.nlm.nih.gov/pmc/articles/pmc8555418/ How I treat microangiopathic hemolytic anemia in patients with cancer]
 
*'''2021:''' Thomas & Scully. [http://www.ncbi.nlm.nih.gov/pmc/articles/pmc8555418/ How I treat microangiopathic hemolytic anemia in patients with cancer]
 +
===[[Venous thromboembolism|Venous thromboembolism (VTE)]]===
 +
*'''2022:''' Schmidt & Lee. [https://doi.org/10.1182/blood.2019003689 How I treat and prevent venous thrombotic complications in patients with lymphoma]
 +
*'''2020:''' Klok & Huisman. [https://doi.org/10.1182/blood.2019001605 How I assess and manage the risk of bleeding in patients treated for venous thromboembolism]
 +
*'''2020:''' Middeldorp & Ganzevoort. [https://doi.org/10.1182/blood.2019000963 How I treat venous thromboembolism in pregnancy]
 +
*'''2020:''' Wang & Carrier. [https://doi.org/10.1182/blood.2019003528 How I treat obese patients with oral anticoagulants]
 +
*'''2019:''' Pabinger & Thaler. [https://doi.org/10.1182/blood.2019002927 How I treat patients with hereditary antithrombin deficiency]
 +
*'''2019:''' Chan & Eikelbloom. [https://doi.org/10.1182/blood-2019-01-846048 How I manage anticoagulant therapy in older individuals with atrial fibrillation or venous thromboembolism]
 +
*'''2019:''' Kraaijpoel & Carrier. [https://doi.org/10.1182/blood-2018-08-835595 How I treat cancer-associated venous thromboembolism]
 +
*'''2018:''' Shet & Wun. [http://www.ncbi.nlm.nih.gov/pmc/articles/pmc6202908/ How I diagnose and treat venous thromboembolism in sickle cell disease]
 
===[[Inherited coagulopathy|von Willebrand disease (vWD)]]===
 
===[[Inherited coagulopathy|von Willebrand disease (vWD)]]===
 
*'''2020:''' Leebeek et al. [https://doi.org/10.1182/blood.2019000964 How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease]
 
*'''2020:''' Leebeek et al. [https://doi.org/10.1182/blood.2019000964 How I manage pregnancy in carriers of hemophilia and patients with von Willebrand disease]

Revision as of 12:29, 7 September 2023

The "How I Treat" series has been published by Blood for several decades and covers a wide variety of topics in malignant and classical hematology. While these articles are not considered to be formal guidelines, they are considered high-level expert opinion. They cover topics ranging from commonly encountered hematologic conditions with a large evidence base, to very rare conditions with only case reports to guide treatment. The purpose of this page is to consolidate the links to all known published How I Treat articles.

Articles are presented by condition, in reverse chronological order. Given the rapid change in evidence in many areas of hematology, readers are encouraged to consider any article published 5+ years ago to be for historical purposes, only.

Note: this page is currently under construction.

Malignant hematology

Myeloid neoplasms

Acute lymphoblastic leukemia (ALL)

Acute myeloid leukemia (AML)

Chronic myeloid leukemia (CML)

Myelodysplastic syndrome (MDS)

Polycythemia vera (PV)

Lymphoid neoplasms

Adult T-cell leukemia-lymphoma (ATLL)

Castleman disease

Chronic lymphocytic leukemia (CLL/SLL)

Cutaneous T-cell lymphoma (CTCL)

Hodgkin lymphoma

Diffuse large B-cell lymphoma (DLBCL)

Follicular lymphoma (FL)

Large granular lymphocytic leukemia (T-LGL)

NK- and T-cell lymphoma

Prolymphocytic leukemia (T-PLL)

Waldenström macroglobulinemia (WM)

Plasma cell dyscrasias

Light-chain (AL) amyloidosis

Multiple myeloma

Histiocytic disorders

Hemophagocytic lymphohistiocytosis (HLH)

Classical hematology

Hemostasis and thrombosis

Acquired thrombotic thrombocytopenic purpura (aTTP)

Antiphospholipid antibody syndrome (APS)

Hemophilia

Thrombotic microangiopathy (TMA)

Venous thromboembolism (VTE)

von Willebrand disease (vWD)

Complications of treatment